Skip to content
Screener

Enovis ENOV Reconstructive — Cost of Goods Sold

Other segment segments

Prevention & Recovery
$124.09M

Similar metrics at other companies

Cal-Maine Foods logo
CALMPrepared Foods — Cost of Goods Sold
$46.34M+4,009%
Flexible Solutions International logo
FSICost of Goods Sold
$6.41M+16.0%
Recursion Pharmaceuticals, Inc. logo
RXRXCost of Goods Sold
$11.49M-43.0%
Owens Corning logo
OCCost of Goods Sold
$1.96B+3.9%
Dynatrace logo
DTCost of Goods Sold
$103.45M+21.4%
Regal Rexnord logo
RRXCost of Goods Sold
$946.8M+1.7%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.53B-5.5%
Enterprise value$2.83B-4.9%
P/S0.7×-0.1×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemThree Months Ended / July 3, 2026Three Months Ended / July 4, 2025Six Months Ended / July 3, 2026Six Months Ended / July 4, 2025
Adjusted EBITDA (non-GAAP)$50,327$46,731$81,436$77,634
Reconstructive:
Net sales$294,534$273,975$611,667$560,225
Segment cost of sales98,87397,750196,208195,024
Segment research and development23,98021,03147,76640,318
Segment operating expense141,376134,729290,659273,666
Total segment expenses264,229253,510534,633509,008
Add: Depreciation23,68923,95749,41849,354

Item 1. Financial Statements

FAQ

What is Enovis's reconstructive — cost of goods sold?
Enovis (ENOV) reported reconstructive — cost of goods sold of $98.87M in Q2 2026.
How has Enovis's reconstructive — cost of goods sold changed year-over-year?
Enovis's reconstructive — cost of goods sold increased by 1.1% year-over-year, from $97.75M to $98.87M.
What is the long-term trend for Enovis's reconstructive — cost of goods sold?
Over 3 years (2022 to 2025), Enovis's reconstructive — cost of goods sold has grown at a 29.5% compound annual growth rate (CAGR), from $171.63M to $372.37M.
What does reconstructive — cost of goods sold mean?
The direct costs associated with manufacturing, sourcing, and delivering the reconstructive medical products and services sold during the period. Monitoring this metric is essential for evaluating the segment's production efficiency and gross margin performance.

Ask your AI about Enovis's reconstructive — cost of goods sold.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude